Szegedi A - Search Results

1

The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression.

Tadić A, Müller MJ, Rujescu D, Kohnen R, Stassen HH, Dahmen N, Szegedi A. Tadić A, et al. Among authors: szegedi a. Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):325-31. doi: 10.1002/ajmg.b.30462. Am J Med Genet B Neuropsychiatr Genet. 2007. PMID: 17192957 Clinical Trial.

2

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

Szegedi A, Müller MJ, Anghelescu I, Klawe C, Kohnen R, Benkert O. Szegedi A, et al. J Clin Psychiatry. 2003 Apr;64(4):413-20. doi: 10.4088/jcp.v64n0410. J Clin Psychiatry. 2003. PMID: 12716243 Clinical Trial.

3

Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis.

Fehr C, Sander T, Tadic A, Lenzen KP, Anghelescu I, Klawe C, Dahmen N, Schmidt LG, Szegedi A. Fehr C, et al. Among authors: szegedi a. Psychiatr Genet. 2006 Feb;16(1):9-17. doi: 10.1097/01.ypg.0000185027.89816.d9. Psychiatr Genet. 2006. PMID: 16395124

4

A monoamine oxidase B gene variant and short-term antidepressant treatment response.

Tadić A, Rujescu D, Müller MJ, Kohnen R, Stassen HH, Dahmen N, Szegedi A. Tadić A, et al. Among authors: szegedi a. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Oct 1;31(7):1370-7. doi: 10.1016/j.pnpbp.2007.05.015. Epub 2007 Jun 7. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17640790 Clinical Trial.

5

Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression.

Tadić A, Rujescu D, Müller MJ, Kohnen R, Stassen HH, Szegedi A, Dahmen N. Tadić A, et al. Among authors: szegedi a. Neuropsychiatr Dis Treat. 2008 Feb;4(1):269-76. doi: 10.2147/ndt.s2262. Neuropsychiatr Dis Treat. 2008. PMID: 18728809 Free PMC article.

6

Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.

Helmreich I, Wagner S, König J, Kohnen R, Szegedi A, Hiemke C, Tadić A. Helmreich I, et al. Among authors: szegedi a. J Affect Disord. 2015 Apr 1;175:199-208. doi: 10.1016/j.jad.2014.12.043. Epub 2014 Dec 24. J Affect Disord. 2015. PMID: 25638793 Clinical Trial.

7

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R. Benkert O, et al. Among authors: szegedi a. J Clin Psychiatry. 2000 Sep;61(9):656-63. doi: 10.4088/jcp.v61n0911. J Clin Psychiatry. 2000. PMID: 11030486 Clinical Trial.

8

Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.

Tadic A, Rujescu D, Szegedi A, Giegling I, Singer P, Möller HJ, Dahmen N. Tadic A, et al. Among authors: szegedi a. Am J Med Genet B Neuropsychiatr Genet. 2003 Feb;117B(1):1-6. doi: 10.1002/ajmg.b.10013. Am J Med Genet B Neuropsychiatr Genet. 2003. PMID: 12555227

9

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression.

Szegedi A, Rujescu D, Tadic A, Müller MJ, Kohnen R, Stassen HH, Dahmen N. Szegedi A, et al. Pharmacogenomics J. 2005;5(1):49-53. doi: 10.1038/sj.tpj.6500289. Pharmacogenomics J. 2005. PMID: 15520843

10

Tyrosine hydroxylase Val-81-Met polymorphism associated with early-onset alcoholism.

Dahmen N, Völp M, Singer P, Hiemke C, Szegedi A. Dahmen N, et al. Among authors: szegedi a. Psychiatr Genet. 2005 Mar;15(1):13-6. doi: 10.1097/00041444-200503000-00003. Psychiatr Genet. 2005. PMID: 15722952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters